Livforsakringsbolaget Skandia Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GAP
The Gap Inc
GAP
|
+$2.74M |
| 2 |
CVS Health
CVS
|
+$2.7M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$2.5M |
| 4 |
IPG
Interpublic Group of Companies
IPG
|
+$2.47M |
| 5 |
Omnicom Group
OMC
|
+$2.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$9.02M |
| 2 |
CA
CA, Inc.
CA
|
+$5.76M |
| 3 |
AET
Aetna Inc
AET
|
+$5.25M |
| 4 |
Magna International
MGA
|
+$4.03M |
| 5 |
Open Text
OTEX
|
+$3.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.1% |
| 2 | Healthcare | 17.32% |
| 3 | Financials | 17.13% |
| 4 | Consumer Discretionary | 12.66% |
| 5 | Communication Services | 10.73% |
Similar funds
Livforsakringsbolaget Skandia's Q4 2018 Portfolio in Review
As of Q4 2018, Livforsakringsbolaget Skandia held 708 positions worth $669M, down 20% from $841M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Livforsakringsbolaget Skandia withdrew a net $56.9M in Q4 2018, closing 70 positions and reducing 14 holdings. Its most notable exit was Medtronic, an estimated $9.02M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Livforsakringsbolaget Skandia opened a new position in Crane NXT worth $946K.
- Livforsakringsbolaget Skandia's largest Q4 2018 buy was Crane NXT: 37,715 shares worth $946K.
- Livforsakringsbolaget Skandia added most to The Gap Inc in Q4 2018, an estimated $2.74M increase.
- Livforsakringsbolaget Skandia's biggest Q4 2018 reduction was NVIDIA, cutting an estimated $2.76M.
- Livforsakringsbolaget Skandia fully exited Medtronic in Q4 2018, selling an estimated $9.02M.
- Livforsakringsbolaget Skandia's ten largest holdings make up 25% of its $669M portfolio in Q4 2018.
- Livforsakringsbolaget Skandia opened 16 new positions and closed 70 in Q4 2018.
- Livforsakringsbolaget Skandia's portfolio value fell 20% quarter-over-quarter to $669M.
Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2018, filed 6 Feb 2019.